Cargando…
Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?
Cyclophosphamide has been the cornerstone of treatment of systemic sclerosis for a long time and is the first-choice therapy for treating systemic sclerosis–associated interstitial lung disease according to the European League Against Rheumatism recommendations on treatment of systemic sclerosis. Ho...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892929/ https://www.ncbi.nlm.nih.gov/pubmed/35382095 http://dx.doi.org/10.1177/2397198320961673 |